18 May 2021
Looking into the treatment of TR with the Edwards portfolio
Sponsored by Edwards Lifesciences
Summary
Watch this session presented by Georg Nickenig, Wolfgang Rottbauer and Ralph von Bardeleben in order to understand the challenges and needs regarding tricuspid valve disease treatment, to learn about the Edwards portfolio for transcatheter treatment of TR, and to discuss patient outcomes with the various treatment options Edwards offers to physicians and patients.
Learning Objectives
- To understand the challenges and needs regarding tricuspid valve disease treatment
- To learn about the Edwards portfolio for transcatheter treatment of TR
- To discuss patient outcomes with the various treatment options Edwards offers to physicians and patients